Hyperchromic anemia is anemia in which red blood cells carry a higher-than-normal concentration of hemoglobin, shown on a blood count as a mean corpuscular hemoglobin concentration (MCHC) above about 36 g/dL. Clinically, a genuinely high MCHC almost always means the cells have become small, dense spheres, most often from hereditary spherocytosis or autoimmune hemolysis. The first job is to rule out a lab artifact; the second is to find the cause of the spherocytes and manage the hemolysis they bring.
From a clinical haematology perspective, hyperchromia is less a diagnosis than a clue. This guide explains what the number means, what causes it, and how patients are investigated and treated.
What “Hyperchromic” Really Means
Red cells, or erythrocytes, are normally flexible discs packed with hemoglobin. Under the microscope they have a paler center, called central pallor, because the disc is thinner in the middle.
A normal cell cannot hold much more hemoglobin than it already does, so true hyperchromia usually means the cell has lost membrane and become a sphere. The same amount of hemoglobin now sits in a smaller, rounder cell, the central pallor disappears, and the MCHC rises.
Patients sometimes see “hyperchromic” used loosely for large-cell (macrocytic) anemias such as vitamin B12 or folate deficiency. In those, each cell contains more hemoglobin in total (a high MCH) because the cell is bigger, but the concentration (MCHC) is normal. That distinction matters, because the causes and treatments are completely different.
| Red cell index | Typical adult reference range | Pattern in true hyperchromic anemia |
|---|---|---|
| MCV (cell size) | 80-100 fL | Normal or slightly low |
| MCH (hemoglobin per cell) | 27-33 pg | Normal |
| MCHC (hemoglobin concentration) | 32-36 g/dL | Raised, above 36 g/dL |
| Reticulocytes | About 0.5-2.5% | Raised when hemolysis is active |
Exact ranges vary slightly between laboratories, so always read results against the range printed on your report.
Causes of a High MCHC
True hyperchromia
- Hereditary spherocytosis (HS): the classic cause. Inherited defects in red cell membrane proteins such as spectrin, ankyrin, band 3, or protein 4.2 make the membrane unstable, so cells shed membrane and become spherical. Most cases are autosomal dominant, meaning one affected parent can pass it on.
- Warm autoimmune hemolytic anemia: antibodies coat red cells and the spleen nibbles off pieces of membrane, producing spherocytes.
- Hereditary xerocytosis: a rarer inherited condition in which cells lose water and become dehydrated and dense.
- Sickle cell disease variants (particularly hemoglobin SC disease) and severe burns can also produce dense, hyperchromic cells.
Spurious (false) hyperchromia
Analyzers can report a high MCHC when the real value is normal. Common culprits include cold agglutinins clumping cells in the tube, very fatty (lipemic) samples, severe jaundice, and hemolysis of the sample during collection. A careful look at the blood smear and a warmed or repeated sample usually sorts this out.
Symptoms and Clinical Picture
The symptoms come from the anemia and from ongoing red cell breakdown (hemolysis):
- Fatigue, pallor, and shortness of breath on exertion.
- Jaundice that may come and go, often worse during infections.
- An enlarged spleen, because the spleen traps and removes the rigid spheres.
- Pigment gallstones, from long-term high bilirubin, sometimes appearing in childhood or early adulthood.
Severity ranges widely. Some people with mild HS are only diagnosed as adults after a routine blood count, while others need transfusions in infancy. Two crises are worth knowing about. A hemolytic crisis is a sudden increase in breakdown, often with a viral illness. An aplastic crisis, classically triggered by parvovirus B19, temporarily shuts down red cell production in the marrow and can cause a steep fall in hemoglobin.
How Hyperchromic Anemia Is Diagnosed
Diagnosis starts with the complete blood count and a look at the blood film, where spherocytes appear as small, dense cells without central pallor. From there, testing aims to confirm hemolysis and identify its cause:
- Hemolysis markers: reticulocyte count, unconjugated bilirubin, LDH, and haptoglobin.
- Direct antiglobulin (Coombs) test: positive in autoimmune hemolysis, negative in hereditary spherocytosis. This single test separates the two main causes.
- EMA binding test: a flow cytometry test that detects reduced band 3 on the membrane, now a preferred screening test for HS.
- Osmotic fragility testing: an older test showing spherocytes burst more easily in dilute salt solutions.
- Family studies and genetic testing in unclear cases or for family planning.
- Abdominal ultrasound to measure the spleen and look for gallstones.
A bone marrow examination is rarely needed, but it may be considered when counts do not fit the picture or when bone marrow disorders are suspected alongside the anemia.
Management Options
Treatment depends on the cause. Autoimmune hemolysis is treated by suppressing the immune response, usually starting with corticosteroids. For hereditary spherocytosis, care focuses on supporting red cell production and preventing complications:
- Folic acid supplements, because an active marrow uses more folate.
- Transfusions during crises or in severe disease, particularly in young children.
- Splenectomy (full or partial) for moderate to severe disease. Removing the spleen stops most of the destruction, although the spherocytes remain on the blood film. It is usually delayed until after early childhood where possible.
- Vaccinations against pneumococcus, meningococcus, and Haemophilus influenzae type b before splenectomy, with advice on prompt treatment of fevers afterward.
- Gallbladder removal if symptomatic gallstones develop, sometimes done at the same operation as splenectomy.
Key Takeaways
- Hyperchromic anemia means a raised MCHC, usually above 36 g/dL, and points toward spherocytes.
- Always exclude spurious results from cold agglutinins, lipemia, or sample problems first.
- The Coombs test separates autoimmune hemolysis from hereditary spherocytosis.
- Most people with HS live normal lives with folic acid, monitoring, and splenectomy when needed. More background is in our anemia hub.
Frequently Asked Questions
Is a high MCHC always a sign of disease?
No. A single high reading is often a lab artifact, especially with cold agglutinins or lipemic samples. Your doctor will review the blood film and may repeat the test before looking further.
Is hyperchromic anemia the same as macrocytic anemia?
No. Macrocytic anemia means large cells, often from B12 or folate deficiency, with a normal MCHC. True hyperchromic anemia means denser cells with a raised MCHC, usually spherocytes.
Can hereditary spherocytosis skip a generation?
Most families show an autosomal dominant pattern, so it typically appears in each generation, although severity can differ between relatives. Some cases arise from new mutations or recessive inheritance, which is why genetic counseling can help.
Will removing the spleen cure the anemia?
In hereditary spherocytosis, splenectomy usually corrects the anemia and stops most hemolysis, though the cells stay spherical. Because it raises lifelong infection risk, the decision is weighed carefully with your hematologist.
Should my children be tested if I have hereditary spherocytosis?
Yes, testing is usually recommended, because early diagnosis helps explain jaundice in newborns and prepares families for possible crises. A blood count, blood film, reticulocyte count, and EMA binding test are typically enough, and your hematologist can advise on timing.
